Literature DB >> 9071727

Stromal tumors of the jejunum and ileum.

J A Tworek1, H D Appelman, T P Singleton, J K Greenson.   

Abstract

Gastrointestinal stromal tumors (GISTs), as currently defined, are mesenchymal tumors of the gastrointestinal tract composed of spindled and/or epithelioid stromal cells that are neither mature Schwann cells nor smooth muscle cells. Many studies have lumped GISTs from all gut sites, when in fact these tumors differ histologically by location. In this study, we evaluated a set of parameters by both univariate and multivariate analysis to determine which parameters correlated with metastases in 36 GISTs from the jejunum and ileum, exclusively. The parameters included organoid architecture, cellularity, mitotic counts, epithelioid cell shape, mucosal invasion, tumor size, skeinoid fibers, nuclear pleomorphism, ischemic necrosis, immunohistochemical differentiation, and proliferating cell nuclear antigen labeling. We evaluated these retrospectively without knowledge as to the metastatic outcome of the tumors. By univariate analysis, dense cellularity, mitotic counts, epithelioid cell shape, mucosal invasion, and size were statistically significant correlates with metastases. By multivariate analysis, only dense cellularity and mitotic counts were independent correlates with metastases. Whether these features are useful predictors of behavior remains to be tested.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9071727

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  17 in total

1.  Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results.

Authors:  Sung Yoon Park; Chan Kyo Kim; Byung Kwan Park; Hyun Moo Lee; Kyung Soo Lee
Journal:  Eur Radiol       Date:  2010-11-03       Impact factor: 5.315

2.  Perforated Meckel's diverticulum presenting as a gastrointestinal stromal tumor: a case report.

Authors:  Martina Hager; Hans Maier; Martin Eberwein; Paul Klingler; Christian Kolbitsch; Werner Tiefenthaler; Gregor Mikuz; Patrizia Lucia Moser
Journal:  J Gastrointest Surg       Date:  2005 Jul-Aug       Impact factor: 3.452

3.  Gastrointestinal stromal tumors: a clinicopathological and immunohistochemical study of 121 cases.

Authors:  Mukul Vij; Vinita Agrawal; Ashok Kumar; Rakesh Pandey
Journal:  Indian J Gastroenterol       Date:  2011-01-11

Review 4.  The histopathological differential diagnosis of gastrointestinal stromal tumours.

Authors:  J F Graadt van Roggen; M L van Velthuysen; P C Hogendoorn
Journal:  J Clin Pathol       Date:  2001-02       Impact factor: 3.411

5.  Prognostic factors and outcome of resected patients with gastrointestinal stromal tumors of small intestine.

Authors:  Rong Fan; Jie Zhong; Zhen-ting Wang; Li-fen Yu; Yong-hua Tang; Wei-guo Hu; Yan-bo Zhu; Xiao-long Jin
Journal:  Med Oncol       Date:  2010-10-08       Impact factor: 3.064

Review 6.  [Gastrointestinal stromal tumors. A morphologic and molecular genetic independent tumor entity with new therapeutic perspectives].

Authors:  G Mechtersheimer; T Lehnert; R Penzel; S Joos; G Egerer; H F Otto
Journal:  Pathologe       Date:  2003-03-21       Impact factor: 1.011

7.  Angiographic findings of gastrointestinal stromal tumor.

Authors:  Song-Hua Fang; Dan-Jun Dong; Shi-Zheng Zhang; Mei Jin
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

Review 8.  The reappraisal of gastrointestinal stromal tumors: from Stout to the KIT revolution.

Authors:  Angelo P Dei Tos
Journal:  Virchows Arch       Date:  2003-02-26       Impact factor: 4.064

Review 9.  Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population.

Authors:  Lori Rink; Andrew K Godwin
Journal:  Curr Oncol Rep       Date:  2009-07       Impact factor: 5.075

10.  Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor.

Authors:  Lori Rink; Yuliya Skorobogatko; Andrew V Kossenkov; Martin G Belinsky; Thomas Pajak; Michael C Heinrich; Charles D Blanke; Margaret von Mehren; Michael F Ochs; Burton Eisenberg; Andrew K Godwin
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.